Allurion: first HealthTech IPO of 2023 via SPAC with Compute Health
Lloyd Price
AUGUST 5, 2023
Additionally, the company has been criticized for its high price tag. In addition to venture capital funding, Allurion has also received funding from the National Institutes of Health (NIH). The NIH grant is supporting the company's research on the use of its gastric balloon for the treatment of obesity.
52 
Let's personalize your content